Everolimus for the Prevention of Microvasculopathy in Biopsy: Final Results from Re-Evaluation of the RAD B253 Trial

Hiemann, N.E.; Bara, C.; Segovia, J.; Parameshwar, J.; Simonsen, S.; Crespo-Leiro, M.; Eiskjaer, H.; Vanhaecke, J.; Arizon, J.M.; Poncelet, Alain; Przybylowski, P.; Frigerio, M.; Lehmkuhl, H.; Meyer, R.

doi:10.1016/j.healun.2011.01.083

Everolimus for the Prevention of Microvasculopathy in Biopsy: Final Results from Re-Evaluation of the RAD B253 Trial

Hiemann, N.E.

;

Bara, C.

;

Segovia, J.

;

Parameshwar, J.

;

Meyer, R.

;et.al.

(2011) 31st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, ISHLT — Location: San Diego, CA, United States (13.April.2011)

Files

Hiemann-2011-31stannualmeetingofISHLT.pdf

Open Access
Adobe PDF
108.53 KB

Download

Details

Authors

Hiemann, N.E.
Author
Bara, C.
Author
Segovia, J.
Author
Parameshwar, J.
Author
Poncelet, AlainUCLouvain
Author
Meyer, R.
Author

Affiliations

Citations

APA
Chicago
FWB

Hiemann, N. E., Bara, C., Segovia, J., Parameshwar, J., Simonsen, S., Crespo-Leiro, M., Eiskjaer, H., Vanhaecke, J., Arizon, J. M., Poncelet, A., Przybylowski, P., Frigerio, M., Lehmkuhl, H., & Meyer, R. (2011). Everolimus for the Prevention of Microvasculopathy in Biopsy: Final Results from Re-Evaluation of the RAD B253 Trial. The Journal of Heart and Lung Transplantation, 30(4), S33. https://doi.org/10.1016/j.healun.2011.01.083 (Original work published 2011)